Welcome to CDC Stacks | U.S. medical eligibility criteria for contraceptive use, 2010; adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition - 5656 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
U.S. medical eligibility criteria for contraceptive use, 2010; adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition
  • Published Date:
    June 18, 2010
Filetype[PDF - 57.55 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
U.S. medical eligibility criteria for contraceptive use, 2010; adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition
Details:
  • Personal Authors:
  • Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Reproductive Health. ; Centers for Disease Control and Prevention (U.S.) ;
  • Description:
    Introduction -- Methods -- How to use this document -- Keeping guidance up to date -- Appendix A. Summary of changes from WHO MEC to U.S. MEC -- Appendix B. Combined hormonal contraceptives -- Appendix C. Progestin-only contraceptives -- Appendix D. Emergency contraceptive pills -- Appendix E. Intrauterine Ddevices -- Appendix F. Copper IUDs for emergency contraception -- Appendix G. Barrier methods -- Appendix H. Fertility awareness-based methods -- Appendix I. Lactational amenorrhea method -- Appendix J. Coitus Interruptus (withdrawal) -- Appendix K. Sterilization -- Appendix L. Summary of hormonal contraceptives and IUDs -- Appendix M. Potential drug interactions: hormonal contraceptives and antiretroviral drugs -- Abbreviations and acronyms -- Participants

    "CDC created U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, from guidance developed by the World Health Organization (WHO) and finalized the recommendations after consultation with a group of health professionals who met in Atlanta, Georgia, during February 2009. This guidance comprises recommendations for the use of specific contraceptive methods by women and men who have certain characteristics or medical conditions. The majority of the U.S. guidance does not differ from the WHO guidance and covers >60 characteristics or medical conditions. However, some WHO recommendations were modified for use in the United States, including recommendations about contraceptive use for women with venous thromboembolism, valvular heart disease, ovarian cancer, and uterine fibroids and for postpartum and breastfeeding women. Recommendations were added to the U.S. guidance for women with rheumatoid arthritis, history of bariatric surgery, peripartum cardiomyopathy, endometrial hyperplasia, inflammatory bowel disease, and solid organ transplantation. The recommendations in this document are intended to assist health-care providers when they counsel women, men, and couples about contraceptive method choice. Although these recommendations are meant to serve as a source of clinical guidance, health-care providers should always consider the individual clinical circumstances of each person seeking family planning services." - P. 1.

    PMID:21734635

  • Document Type:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: